EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort

Giulia Peduzzi iD, Roberto Pellungrini, Livia Archibugi, Federico Canzian iD, Cosmeri Rizzato, Gabriele Capurso, Daniele Campa

United European Gastroenterology Journal · 2025

DOI: 10.1002/ueg2.70102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Giulia Peduzzi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Università di Pisa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of pancreatic ductal adenocarcinoma (PDAC) is lower in females than males (19.0 vs. 20.2 for 100,000 individuals in Europe). This disparity is commonly attributed to differences in exposure to lifestyle risk factors such as smoking and alcohol consumption; however, hormonal activity may also play a role.

Objective

This study aimed to comprehensively examine the role of hormone exposure and reproductive factors in males and females in PDAC susceptibility.

Methods

We analyzed 816 PDAC cases and 302,645 controls from the UK Biobank prospective cohort. Twenty hormone‐related variables and a polygenic risk score (PRS) were examined in females and males using epidemiological methods and machine learning algorithms.

Results

Oral contraceptives (OC) use increased PDAC risk (OR = 2.17 (95% CI: 1.70–2.80), p = 8.16 × 10 −10 ), while each full‐term pregnancy decreased it (OR = 0.83 (95% CI: 0.76–0.90), p = 2.60 × 10 −5 ). In males increased level of sex hormone‐binding globulin (SHBG) was associated with a decreased risk (OR = 0.98, 95% CI: 0.97–0.98, p = 7.38 × 10 −10 ). The machine learning model performed well in both sexes, with AUCs of 0.95 and 0.92, specificity of 0.86 and 0.92 and sensitivity of 0.90 and 0.81 for females and males, respectively. The use of an explainer identified age and the PRS as significant features for both sexes, with additional factors such as age at menopause and OC use for females, and SHBG concentration in blood for males.

Conclusion

We observed a consistent protective effect of the factors that decrease‐the exposure to menstrual cycle related hormones. Additionally, exogenous hormones increase due to long exposure to OC and HRT increases the risk of the disease. Therefore, our result suggests that it is more important to which hormones an individual is exposed compared to the overall increase or decrease in exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansFemaleMaleUnited KingdomMiddle AgedRisk FactorsAgedSex FactorsProspective StudiesBiological Specimen BanksCase-Control StudiesContraceptives, OralMachine LearningSex Hormone-Binding GlobulinRisk AssessmentIncidenceAdultPregnancyUK Biobank

Substanzen

Contraceptives, OralSex Hormone-Binding Globulin

Autor:innen und Institutionen

  • Department of Biology, University of Pisa, Pisa, Italy.
  • Classe di Scienze, Scuola Normale Superiore, Pisa, Italy.
  • Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Centre, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.
  • Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

ORCID-Profile: Giulia Peduzzi, Federico Canzian

Förderung

  • Università di Pisa

Zitieren

APA

Peduzzi, G., Pellungrini, R., Archibugi, L., Canzian, F., Rizzato, C., Capurso, G., & Campa, D. (2025). Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70102

Vancouver

Peduzzi G, Pellungrini R, Archibugi L, Canzian F, Rizzato C, Capurso G, et al. Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70102

BibTeX
@article{Peduzzi2025,
  author = {Peduzzi, Giulia and Pellungrini, Roberto and Archibugi, Livia and Canzian, Federico and Rizzato, Cosmeri and Capurso, Gabriele and Campa, Daniele},
  title = {Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  doi = {10.1002/ueg2.70102}
}
Kostenlos starten →